| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |